Clinical Trials in Houston

Showing 4961-4980 of 13,620 trials

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

NCT04271332

This Phase 2 study examines the safety, tolerability, and efficacy of arbaclofen in pediatric subjects with 16p11.2 deletion. Male or female subjects aged 5 to 17 years of age will be randomized to receive either placebo or arbaclofen in a double-blind study design. If the subject completes all study requirements through Visit 4 (Close-out Visit), he/she may be eligible for an optional open-label study with arbaclofen.

16P11.2 Deletion Syndrome

Clinical Research Associates, LLC60 participantsStarted Sep 2022

Boston, Massachusetts, United States • New York, New York, United States • Houston, Texas, United States +1 more locations

RECRUITINGNA< 1 mile

Implementation and Evaluation of an Evidence-Based, Multilevel Lifestyle Intervention for Underserved and Rural Populations in South Texas

NCT06433258

The purpose of this study is to enhance the current TSSC multilevel intervention delivered in Cameron and Hidalgo counties by adding additional components including an educational module on the risks of alcohol intake and its connection to cancer, as well as developing training and referral systems to address social determinants of health (SDOH) that negatively impact uptake of cancer prevention behaviors.

Cancer Prevention

The University of Texas Health Science Center, Houston500 participantsStarted May 2024

Houston, Texas, United States

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Implementation and Evaluation of an Evidence-Based, Multilevel Lifestyle Intervention for Underserved and Rural Populations in South Texas

Find Trials by Condition in Houston

Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa

Predictors of Severe COVID-19 Outcomes

A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Enhancing Food as Medicine Interventions for Food Insecure Postpartum Women in Central Texas

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women

MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients

Safety and Efficacy of Emixustat in Stargardt Disease

IN.PACT™ AV Access IDE Study

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain